Vertrix Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$637K Buy
3,945
+611
+18% +$102K 0.22% 73
2026
Q2
$632K Buy
3,334
+37
+1% +$6.96K 0.21% 73
2026
Q1
$650K Buy
+3,297
New +$636K 0.24% 70

Other funds holding AZN

Vertrix Wealth Management's AZN Position: Q3 2026 in Review

Vertrix Wealth Management increased its AstraZeneca (AZN) stake by 18% in Q3 2026, buying an estimated $102K and bringing the position to 3,945 shares worth $637K. The position accounts for 0.22% of the portfolio, ranked #73.

Vertrix Wealth Management first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $650K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Vertrix Wealth Management held 3,945 shares of AstraZeneca worth $637K as of Q3 2026.
  • Vertrix Wealth Management bought 611 AstraZeneca shares in Q3 2026, an estimated $102K.
  • AstraZeneca made up 0.22% of Vertrix Wealth Management's portfolio in Q3 2026, its #73 holding.
  • Vertrix Wealth Management first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
  • Vertrix Wealth Management's AstraZeneca position peaked at $650K in Q1 2026.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Vertrix Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.